Compare Nuvalent Inc (NUVL) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Quantumscape Corp — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Quantumscape Corp trades at $6.07 (market cap $3.62B). The key difference: Nuvalent Inc is far larger — about 2.7× Quantumscape Corp's market cap, and Nuvalent Inc is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| NUVL | QS | |
|---|---|---|
Market Cap | $9.81B | $3.62B |
Sector | Technology | Consumer Cyclical |
52-Week High | $123.96 | $18.44 |
52-Week Low | $72.16 | $5.86 |
Enterprise Value | $8.52B | $2.79B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
